Skip to main content

MiniMed Group, Inc.

For the period ended Jan 23, 2026. Filed Apr 17, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jan 23, 2026 · Filed Apr 17, 2026

MMED$16.71-8.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. Financial Statements (Unaudited)

CONDENSED COMBINED STATEMENTS OF OPERATIONS

Three Months EndedNine Months Ended
(in millions, except share and per share data)January 23, 2026January 24, 2025January 23, 2026January 24, 2025
Net sales$790$687$2,265$1,991
Cost of products sold4282921,065869
Gross Profit3623951,2001,123
Operating expenses:
Research and development expense114112349329
Selling, general, and administrative expense309268884804
Certain litigation charges, net(6)—11—
Other operating expense (income), net45(7)53(12)
Operating (loss) profit(100)21(97)2
Other non-operating (income) expense, net———1
(Loss) profit before income taxes(99)21(97)1
Income tax provision12283531
Net loss(111)(7)(132)(30)
Net income attributable to noncontrolling interests(8)(3)(16)(10)
Net loss attributable to the Company$(119)$(10)$(148)$(41)
Loss per share:
Basic and diluted$(0.47)$(0.04)$(0.59)$(0.16)
Weighted-average shares outstanding
Basic and diluted252,813,348252,813,348252,813,348252,813,348

CONDENSED COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

Three Months EndedNine Months Ended
(in millions)January 23, 2026January 24, 2025January 23, 2026January 24, 2025
Net loss$(111)$(7)$(132)$(30)
Other comprehensive income (loss), net of tax:
Translation adjustment5(10)11(7)
Other comprehensive income (loss), net of tax:5(10)11(7)
Comprehensive loss attributable to the Company$(106)$(17)$(121)$(37)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.